Edwards Lifesciences (EW) Acquisitions (2011 - 2019)

Edwards Lifesciences' Acquisitions history runs 6 years deep, the most recent figure standing at $98.9 million for Q2 2019.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $98.9 million in Q2 2019; TTM through Sep 2020 was $98.9 million, a 1.3% decrease from a year earlier, with the FY2019 full-year figure at $100.2 million, changed N/A from the prior year.
• Acquisitions grew to $98.9 million in Q2 2019 per EW's latest filing, from $1.3 million in the prior quarter.
• Across five years, Acquisitions topped out at $330.8 million in Q4 2015 and bottomed at -$2.0 million in Q2 2016.
• The 4-year median for Acquisitions is $1.8 million (2015), against an average of $62.5 million.
• Biggest YoY gain for Acquisitions was 4350.0% in 2017; the steepest drop was 110.0% in 2017.
• Year by year, Acquisitions stood at $330.8 million in 2015, then sank by 100.6% to -$2.0 million in 2016, then jumped by 5500.0% to $108.0 million in 2017, then dropped by 8.43% to $98.9 million in 2019.
• Per Business Quant, the three latest EW Acquisitions figures stand at $98.9 million (Q2 2019), $1.3 million (Q1 2019), and $108.0 million (Q4 2017).